Effect of glutamine synthetase inhibition on brain and interorgan ammonia metabolism in bile duct ligated rats

Journal of Cerebral Blood Flow and Metabolism

Volumn 34, Issue 3, 2014, Pages 460-466

  Fries, Andreas W ^a   Dadsetan, Sherry ^b   Keiding, Susanne ^a   Bak, Lasse K ^b   Schousboe, Arne ^b   Waagepetersen, Helle S ^b   Simonsen, Mette ^a   Ott, Peter ^a   Vilstrup, Hendrik ^a   Sørensen, Michael ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

alanine; amino acids; hepatic encephalopathy; hyperammonemia; methionine sulfoximine (MSO)

Indexed keywords

ALANINE; AMMONIA; ASPARTIC ACID; GLUTAMATE AMMONIA LIGASE; GLUTAMIC ACID; GLUTAMINE; METHIONINE SULFOXIMINE; NITROGEN 15;

AMINO ACID BLOOD LEVEL; AMINO ACID BRAIN LEVEL; AMMONIA METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BILE DUCT; BILE DUCT LIGATION; BRAIN; COCULTURE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; ISOTOPE LABELING; KIDNEY; LIVER; METABOLISM; MUSCLE; NONHUMAN; PLASMA; PRIORITY JOURNAL; RAT; SYNTHESIS;

AMINO ACIDS; AMMONIA; ANIMALS; BRAIN; FEMALE; GLUTAMATE-AMMONIA LIGASE; HEPATIC ENCEPHALOPATHY; KIDNEY; LIVER; METHIONINE SULFOXIMINE; ORGAN SPECIFICITY; RATS; RATS, WISTAR;

EID: 84896708058     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2013.218     Document Type: Article

References (40)

1. Keiding S, S?rensen M, Bender D, Munk OL, Ott P, Vilstrup H. Brain metabolism of 13N-Ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography. Hepatology 2006; 43: 42-50
2. Correction in Hepatology. 2003; 44:1056.
3. Dam G, Keiding S, Munk OL, Ott P, Vilstrup H, Bak LK et al. Hepatic encephalopathy is associated with decreased cerebral oxygen metabolism and blood flow, not increased ammonia uptake. Hepatology 2013; 57: 258-265.
4. Albrecht J, Jones EA. Hepatic encephalopathy: Molecular mechanisms underlying the clinical syndrome. J Neurol Sci 1999; 170: 138-146.
5. Berl S, Takagaki G, Clarke DD, Waelsch H. Metabolic comparments in vivo. J Biol Chem 1962; 237: 2562-2569.
6. Norenberg MD, Martinez-Hernandez A. Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res 1979; 161: 303-310.
7. Cooper AJ, McDonald JM, Gelbard AS, Gledhill RF, Duffy TE. The metabolic fate of 13N-labeled ammonia in rat brain. J Biol Chem 1979; 254: 4982-4992.
8. Hawkins RA, Jessy J. Hyperammonaemia does not impair brain function in the absence of net glutamine synthesis. Biochem J 1991; 277: 697-703.
9. Swain M, Butterworth RF, Blei AT. Ammonia and related amino acids in the pathogenesis of brain edema in acute ischemic liver failure in rats. Hepatology 1992; 15: 449-453.
10. Dejong CH, Deutz NE, Soeters PB. Cerebral cortex ammonia and glutamine metabolism in two rat models of chronic liver insufficiency-induced hyperammonemia: Influence of pair-feeding. J Neurochem 1993; 60: 1047-1057.
11. Tofteng F, Hauerberg J, Hansen BA, Pedersen CB, Jorgensen L, Larsen FS. Persistent arterial hyperammonemia increases the concentration of glutamine and alanine in the brain and correlates with intracranial pressure in patients with fulminant hepatic failure. J Cereb Blood Flow Metab 2006; 26: 21-27.
12. Shah NJ, Neeb H, Kircheis G, Engels P, Ha?ussinger D, Zilles K. Quantitative cerebral water content mapping in hepatic encephalopathy. Neuroimage 2008; 41: 706-717.
13. Bjerring PN, Hauerberg J, Frederiksen HJ, Jorgensen L, Hansen BA, Tofteng F et al. Cerebral glutamine concentration and lactate-pyruvate ratio in patients with acute liver failure. Neurocrit Care 2008; 9: 1-7.
14. Rama Rao KV, Jayakumar AR, Norenberg MD. Glutamine in the pathogenesis of acute hepatic encephalopathy. Neurochem Int 2012; 61: 575-580.
15. Leke R, Bak LK, Anker M, Melo TM, S?rensen M, Keiding S et al. Detoxification of ammonia in mouse cortical GABAergic cell cultures increases neuronal oxidative metabolism and reveals an emerging role for release of glucose-derived alanine. Neurotox Res 2011; 19: 496-510.
16. Dadsetan S, Bak LK, S?rensen M, Keiding S, Vilstrup H, Ott P et al. Inhibition of glutamine synthesis induces glutamate dehydrogenase-dependent ammonia fixation into alanine in co-cultures of astrocytes and neurons. Neurochem Int 2011; 59: 482-488.
17. Dadsetan S, Kukolj E, Bak LK, S?rensen M, Ott P, Vilstrup H et al. Brain alanine formation as an ammonia scavenging pathway during hyperammonemia: effects of glutamine synthetase inhibition in rats and astrocyte-neuron co-cultures. J Cereb Blood Flow Metab 33: 1235-1241.
18. Warren KS, Schenker S. Effect of an inhibitor of glutamine synthesis (methionine sulfoximine) on ammonia toxicity and metabolism. J Lab Clin Med 1964; 64: 442-449.
19. Takahashi H, Koehler RC, Brusilow SW, Traystman RJ. Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats. Am J Physiol 1991; 261: H825-H829.
20. Blei AT, Olafsson S, Therrien G, Butterworth RF. Ammonia-induced brain edema and intracranial hypertension in rats after portacaval anastomosis. Hepatology 1994; 19: 1437-1444.
21. Willard-Mack CL, Koehler RC, Hirata T, Cork LC, Takahashi H, Traystman RJ et al. Inhibition of glutamine synthetase reduces ammonia-induced astrocyte swelling in rat. Neuroscience 1996; 71: 589-599.
22. Tanigami H, Rebel A, Martin LJ, Chen TY, Brusilow SW, Traystman RJ et al. Effect of glutamine synthetase inhibition on astrocyte swelling and altered astroglial protein expression during hyperammonemia in rats. Neuroscience 2005; 131: 437-449.
23. Rao SL, Meister A. In vivo formation of methionine sulfoximine phosphate, a protein-bound metabolite of methionine sulfoximine. Biochemistry 1972; 11: 1123-1127.
24. Butterworth RF, Norenberg MD, Felipo V, Ferenci P, Albrecht J, Blei AT. Members of the ISHEN Commission on Experimental Models of HE. Experimental models of hepatic encephalopathy: ISHEN guidelines. Liver Int 2009; 29: 783-788.
25. Bak LK, Iversen P, S?rensen M, Keiding S, Vilstrup H, Ott P et al. Metabolic fate of isoleucine in a rat model of hepatic encephalopathy and in cultured neural cells exposed to ammonia. Metab Brain Dis 2009; 24: 135-145.
26. van Anken HC, Schiphorst ME. A kinetic determination of ammonia in plasma. Clin Chim Acta 1974; 56: 151-157.
27. Mawhinney TP, Robinett RS, Atalay A, Madson MA. Analysis of amino acids as their tert.-butyldimethylsilyl derivatives by gas-liquid chromatography and mass spectrometry. J Chromatogr 1986; 358: 231-242.
28. Biemann K. Mass spectrometry. In: Biemann K (ed). Organic Chemistry Applications. McGraw: New York, NY, USA, 1962, pp 223-227.
29. Geddes JW, Wood JD. Changes in the amino acid content of nerve endings (synaptosomes) induced by drugs that alter the metabolism of glutamate and gamma-Aminobutyric acid. J Neurochem 1984; 42: 16-24.
30. Lowry OH, Rosebough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
31. Oldendorf WH, Szabo J. Amino acid assignment to one of three blood-brain barrier amino acid carriers. Am J Physiol 1976; 230: 94-98.
32. Hawkins RA, O?Kane RL, Simpson IA, Vina JR. Structure of the blood-brain barrier and its role in the transport of amino acids. J Nutr 2006; 136(1 Suppl): 218S-226S.
33. Dam G, Keiding S, Munk OL, Ott P, Buhl M, Vilstrup H et al. Branched-chain amino acids increase arterial blood ammonia in spite of enhanced intrinsic muscle ammonia metabolism in patients with cirrhosis and healthy subjects. Am J Physiol Gastrointest Liver Physiol 2011; 301: G269-G277.
34. Olde Damink SW, Jalan R, Redhead DN, Hayes PC, Deutz NE, Soeters PB. Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS. Hepatology 2002; 36: 1163-1171.
35. Clemmesen JO, Kondrup J, Ott P. Splanchnic and leg exchange of amino acids and ammonia in acute liver failure. Gastroenterology 2000; 118: 1131-1139.
36. Keiding S, S?rensen M, Munk OL, Bender D. Human 13N-Ammonia PET studies: the importance of measuring 13N-Ammonia metabolites in blood. Metab Brain Dis 2010; 25: 49-56.
37. Brusilow SW, Koehler RC, Traystman RJ, Cooper AJ. Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy. Neurotherapeutics 2010; 7: 452-470.
38. Cooper AJL. Possible treatment of end-stage hyperammonemic encephalopathy by inhibition of glutamine synthetase. Metab Brain Dis 2013; 28: 119-125.
39. Brumback RA, Lapham LW. DNA synthesis in Alzheimer type II astrocytosis. the question of astrocytic proliferation and mitosis in experimentally induced hepatic encephalopathy. Arch Neurol 1989; 46: 845-848.
40. Gershoff SN, Elvehjem CA. The relative effect of methionine sulfoximine on different animal species. J Nutr 1951; 45: 451-458.